![CD4+CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART | Journal of Translational Medicine | Full Text CD4+CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-020-02245-8/MediaObjects/12967_2020_2245_Fig1_HTML.png)
CD4+CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART | Journal of Translational Medicine | Full Text
![High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort | BMC Infectious Diseases | Full Text High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2334-11-43/MediaObjects/12879_2010_Article_1400_Fig2_HTML.jpg)
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort | BMC Infectious Diseases | Full Text
![Flow cytometry gating strategy for measuring HLA-DR and CD38 expression... | Download Scientific Diagram Flow cytometry gating strategy for measuring HLA-DR and CD38 expression... | Download Scientific Diagram](https://www.researchgate.net/publication/338622667/figure/fig1/AS:848639643623424@1579342866645/Flow-cytometry-gating-strategy-for-measuring-HLA-DR-and-CD38-expression-on-CD4-T-cells.png)
Flow cytometry gating strategy for measuring HLA-DR and CD38 expression... | Download Scientific Diagram
![Presence of HLA‐DR Molecules and HLA‐DRB1 mRNA in Circulating CD4+ T Cells - Revenfeld - 2016 - Scandinavian Journal of Immunology - Wiley Online Library Presence of HLA‐DR Molecules and HLA‐DRB1 mRNA in Circulating CD4+ T Cells - Revenfeld - 2016 - Scandinavian Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d2b9b9a4-495d-451c-9fc6-ee112fbe800e/sji12462-fig-0001-m.jpg)
Presence of HLA‐DR Molecules and HLA‐DRB1 mRNA in Circulating CD4+ T Cells - Revenfeld - 2016 - Scandinavian Journal of Immunology - Wiley Online Library
![JoF | Free Full-Text | Longitudinal Changes in CD4+, CD8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococcal Meningitis JoF | Free Full-Text | Longitudinal Changes in CD4+, CD8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococcal Meningitis](https://www.mdpi.com/jof/jof-05-00063/article_deploy/html/images/jof-05-00063-g001.png)
JoF | Free Full-Text | Longitudinal Changes in CD4+, CD8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococcal Meningitis
![Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency | SpringerLink Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10875-021-01084-6/MediaObjects/10875_2021_1084_Fig2_HTML.png)
Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency | SpringerLink
![Considerations for cancer immunotherapy biomarker research during COVID-19 in: Endocrine-Related Cancer Volume 27 Issue 9 (2020) Considerations for cancer immunotherapy biomarker research during COVID-19 in: Endocrine-Related Cancer Volume 27 Issue 9 (2020)](https://erc.bioscientifica.com/view/journals/erc/27/9/images/ERC-20-0187fig2.jpeg)
Considerations for cancer immunotherapy biomarker research during COVID-19 in: Endocrine-Related Cancer Volume 27 Issue 9 (2020)
![Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model? - Cytotherapy Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model? - Cytotherapy](https://www.isct-cytotherapy.org/cms/asset/8df50ab1-cfb5-4f27-b8a8-5a4e2a29d00f/gr1.jpg)
Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model? - Cytotherapy
![Frequency of activated CD4+ T cells across HIV-1 disease states. CD38... | Download Scientific Diagram Frequency of activated CD4+ T cells across HIV-1 disease states. CD38... | Download Scientific Diagram](https://www.researchgate.net/publication/257888319/figure/fig3/AS:216396182102020@1428604278684/Frequency-of-activated-CD4-T-cells-across-HIV-1-disease-states-CD38-and-HLA-DR.png)
Frequency of activated CD4+ T cells across HIV-1 disease states. CD38... | Download Scientific Diagram
![Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-13-03841/article_deploy/html/images/cancers-13-03841-ag.png?1628043076)
Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
![Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor - ScienceDirect Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001621005840-gr1.jpg)
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor - ScienceDirect
![Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram](https://www.researchgate.net/publication/49742362/figure/fig1/AS:202968864432134@1425402956239/Expression-of-activation-CD38-and-HLA-DR-and-senescence-CD57-and-CD28-markers-on-CD4.png)
Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram
![T-cell activation without proliferation in juvenile idiopathic arthritis | Arthritis Research & Therapy | Full Text T-cell activation without proliferation in juvenile idiopathic arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Far403/MediaObjects/13075_2001_403_Fig1_HTML.jpg)
T-cell activation without proliferation in juvenile idiopathic arthritis | Arthritis Research & Therapy | Full Text
![Early (CD69) and late (HLA-DR) activation marker expression by T cells... | Download Scientific Diagram Early (CD69) and late (HLA-DR) activation marker expression by T cells... | Download Scientific Diagram](https://www.researchgate.net/publication/7847514/figure/fig4/AS:277901137203203@1443268202161/Early-CD69-and-late-HLA-DR-activation-marker-expression-by-T-cells-in-matched-n.png)
Early (CD69) and late (HLA-DR) activation marker expression by T cells... | Download Scientific Diagram
Potential Role for HIV-Specific CD38−/HLA-DR+ CD8+ T Cells in Viral Suppression and Cytotoxicity in HIV Controllers | PLOS ONE
![JCI Insight - Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial JCI Insight - Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial](https://df6sxcketz7bb.cloudfront.net/manuscripts/98000/98960/medium/jci.insight.98960.f8.jpg)
JCI Insight - Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
![Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy](https://www.frontiersin.org/files/Articles/415038/fimmu-09-02605-HTML/image_m/fimmu-09-02605-g001.jpg)
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
![Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis - ScienceDirect Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867418310274-fx1.jpg)